Gene · 3491
Papers4,514
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,514
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of Gestational Arsenic Exposures on Placental and Fetal Development in Mice: The Role of Cyr61 m6A. | Environ Health Perspect | 2023 | 37682722 | PubTator, text mining | PubMed |
| Genetic and Pharmacological YAP Activation Induces Proliferation and Improves Survival in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. | Cells | 2023 | 37681853 | PubTator, text mining | PubMed |
| Tensin-3 is involved in osteogenic versus adipogenic fate of human bone marrow stromal cells. | Cell Mol Life Sci | 2023 | 37668682 | PubTator, text mining | PubMed |
| Ligand-independent signaling and migration of breast cancer cells expressing membrane androgen receptor, ZIP9 (SLC39A9). | Mol Cell Endocrinol | 2023 | 37660782 | PubTator, text mining | PubMed |
| The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability. | Cell Rep Med | 2023 | 37652015 | PubTator, text mining | PubMed |
| Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma. | J Cancer Res Clin Oncol | 2023 | 37639012 | PubTator, text mining | PubMed |
| The Role of Hedgehog Signaling Pathway in Head and Neck Squamous Cell Carcinoma. | Cells | 2023 | 37626893 | PubTator, text mining | PubMed |
| Zyxin Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma via Rap1-Mediated Inhibition of the MEK/ERK Signaling Pathway. | Biomedicines | 2023 | 37626810 | PubTator, text mining | PubMed |
| Adipocyte regulation of cancer stem cells. | Cancer Sci | 2023 | 37622414 | PubTator, text mining | PubMed |
| A Comprehensive Insight and Mechanistic Understanding of the Lipidomic Alterations Associated With DCM. | JACC Asia | 2023 | 37614533 | PubTator, text mining | PubMed |
| Immune changes induced by periampullary adenocarcinoma are reversed after tumor resection and modulate the postoperative survival. | Discov Oncol | 2023 | 37610509 | PubTator, text mining | PubMed |
The impact of interaction between verteporfin and yes-associated protein 1/transcriptional coactivator with PDZ-binding motif-TEA domain pathway on the progression of isocitrate dehydrogenase wild-type glioblastoma. | J Cent Nerv Syst Dis | 2023 | 37600236 | PubTator, text mining | PubMed |
| Neuromedin U contributes to radiation resistance in colorectal cancer via YAP/TAZ signaling activation. | Oncol Rep | 2023 | 37594135 | PubTator, text mining | PubMed |
| Dual roles of cellular communication network factor 6 (CCN6) in the invasion and metastasis of oral cancer cells to bone via binding to BMP2 and RANKL. | Carcinogenesis | 2023 | 37590989 | PubTator, text mining | PubMed |
| Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors. | EMBO Mol Med | 2023 | 37587872 | PubTator, text mining | PubMed |
| CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties. | Signal Transduct Target Ther | 2023 | 37582812 | PubTator, text mining | PubMed |
| Hydrogel platform facilitating astrocytic differentiation through cell mechanosensing and YAP-mediated transcription. | Mater Today Bio | 2023 | 37576868 | PubTator, text mining | PubMed |
| YAP/TAZ: Molecular pathway and disease therapy. | MedComm (2020) | 2023 | 37576865 | PubTator, text mining | PubMed |
| YAP at the Crossroads of Biomechanics and Drug Resistance in Human Cancer. | Int J Mol Sci | 2023 | 37569866 | PubTator, text mining | PubMed |
| The Therapeutic Potential of a Strategy to Prevent Acute Myeloid Leukemia Stem Cell Reprogramming in Older Patients. | Int J Mol Sci | 2023 | 37569414 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3491/papers?page=19